Lundgaard Maja Hjelm, Bruun Niels Henrik, Handberg Aase, Andersen Stig, Andersen Stine Linding
Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark.
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
J Appl Lab Med. 2025 Jul 1;10(4):949-962. doi: 10.1093/jalm/jfaf064.
Placental dysfunction is important to recognize, and more evidence is needed on the dynamics of the placental biomarkers, soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PlGF), in early pregnancy. This study aimed to establish reference intervals for placental biomarkers in early pregnancy.
This was a retrospective cohort study of pregnant women (n = 702) in the North Denmark Region, 2013, who had blood samples drawn in early pregnancy including measurements of sFlt-1 and PlGF (Kryptor Compact, Thermofisher Scientific). Reference intervals were established, and the association between sFlt-1 and PlGF and maternal characteristics (age, body mass index [BMI], country of birth, and smoking in pregnancy) was evaluated using linear regression analyses and reported as adjusted beta coefficient (aβ) with 95% confidence intervals (CIs).
The placental biomarkers showed a dynamic trend with higher levels for increasing week of pregnancy; however, sFlt-1 reached a plateau around week 10 of pregnancy. Higher maternal age associated with higher sFlt-1 and PlGF (sFlt-1: aβ 1.02 [95% CI, 1.01-1.03], PlGF: aβ 1.02 [95% CI, 1.01-1.03]), and higher maternal BMI associated with lower sFlt-1 (aβ 0.97 [95% CI, 0.96-0.98]). Furthermore, the level of PlGF was higher among women born outside of Denmark (aβ 1.17 [95% CI, 1.03-1.34]) compared to women born in Denmark and among smokers (aβ 1.56 [95% CI, 1.38-1.78]) compared to nonsmokers.
In a large cohort of pregnant women in Denmark, levels of sFlt-1 and PlGF increased during early pregnancy and were influenced by a series of maternal characteristics.
胎盘功能障碍的识别很重要,关于妊娠早期胎盘生物标志物可溶性fms样酪氨酸激酶-1(sFlt-1)和胎盘生长因子(PlGF)动态变化的证据仍需更多。本研究旨在确定妊娠早期胎盘生物标志物的参考区间。
这是一项对2013年丹麦北部地区702名孕妇进行的回顾性队列研究,这些孕妇在妊娠早期采集了血样,包括sFlt-1和PlGF的检测(Kryptor Compact,赛默飞世尔科技公司)。确定了参考区间,并使用线性回归分析评估sFlt-1和PlGF与母亲特征(年龄、体重指数[BMI]、出生国家和孕期吸烟情况)之间的关联,并报告为调整后的β系数(aβ)及95%置信区间(CIs)。
胎盘生物标志物呈现动态变化趋势,随着孕周增加水平升高;然而,sFlt-1在妊娠第10周左右达到平台期。母亲年龄越大,sFlt-1和PlGF水平越高(sFlt-1:aβ 1.02 [95% CI,1.01 - 1.03],PlGF:aβ 1.02 [95% CI,1.01 - 1.03]),母亲BMI越高,sFlt-1水平越低(aβ 0.97 [95% CI,0.96 - 0.98])。此外,与丹麦出生的女性相比,丹麦境外出生的女性PlGF水平更高(aβ 1.17 [95% CI,1.03 - 1.34]),与非吸烟者相比,吸烟者的PlGF水平更高(aβ 1.56 [95% CI,1.38 - 1.78])。
在丹麦的一大群孕妇中,sFlt-1和PlGF水平在妊娠早期升高,并受到一系列母亲特征的影响。